Back

Atrial fibrillation in patients with heart failure with reduced ejection fraction: a real-world analysis on renal function and left ventricular ejection fraction changes with outcome implications

29 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Optimising care of comorbidities in heart failure Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marta Mantovani

Modena Polyclinic Modena University Hospital, Modena (Italy)

6 More presentations in this session

Presentation thumbnail
Associations between rapid renal function decline and prior cardiovascular events in patients with heart failure and preserved ejection fraction: insights from the PURSUIT-HFpEF registry
Doctor M. Okada (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Predictors and prognostic impact of chronic kidney disease in hospitalized patients with heart failure - insights from the cardiomining study
Doctor K. Barmpagiannos (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data
Associate Professor A. Kalogeropoulos (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Hyperkalaemia in patients with heart failure in German general practices: prevalence, diagnosis and treatment: The WATCH-K study
Professor I. Eitel (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics, prescribing patterns and outcomes in individuals with heart failure and type 1 diabetes versus type 2 diabetes
Doctor Y. Liew (Dundee, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising care of comorbidities in heart failure

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction
thumbnail
Congress Presentation
Prognostic implications of renal function trajectories in heart failure management
thumbnail
Congress Presentation
Real world data using sacubitril/valsartan in CKD stage 4 and 5 is associated with improved ejection fraction and may have renoprotective effects.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources